192 related articles for article (PubMed ID: 11721457)
1. Significance of anti-neutrophil cytoplasmic antibodies in patients with pauci-immune crescentic glomerulonephritis.
Tang Z; Zhou H; Zhang S; Yao X; Hu W; Liu Z; Li L
Chin Med J (Engl); 1999 Dec; 112(12):1143-6. PubMed ID: 11721457
[TBL] [Abstract][Full Text] [Related]
2. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis.
Rutgers A; Slot M; van Paassen P; van Breda Vriesman P; Heeringa P; Tervaert JW
Am J Kidney Dis; 2005 Aug; 46(2):253-62. PubMed ID: 16112043
[TBL] [Abstract][Full Text] [Related]
3. Anti-endothelial cell antibodies in antineutrophil cytoplasmic antibodies negative pauci-immune crescentic glomerulonephritis.
Cong M; Chen M; Zhang JJ; Hu Z; Zhao MH
Nephrology (Carlton); 2008 Jun; 13(3):228-34. PubMed ID: 18315705
[TBL] [Abstract][Full Text] [Related]
4. Pauci-immune crescentic glomerulonephritis associated with ANCA of IgA class.
Bollée G; Noël LH; Suarez F; Royal V; Gilardin L; de Serre NP; El-Ghoul B; Lesavre P; Alyanakian MA; Fakhouri F
Am J Kidney Dis; 2009 Jun; 53(6):1063-7. PubMed ID: 19084310
[TBL] [Abstract][Full Text] [Related]
5. Antineutrophil cytoplasmic autoantibody-negative Pauci-immune crescentic glomerulonephritis.
Chen M; Yu F; Wang SX; Zou WZ; Zhao MH; Wang HY
J Am Soc Nephrol; 2007 Feb; 18(2):599-605. PubMed ID: 17215440
[TBL] [Abstract][Full Text] [Related]
6. ANCA-negative pauci-immune renal vasculitis: histology and outcome.
Eisenberger U; Fakhouri F; Vanhille P; Beaufils H; Mahr A; Guillevin L; Lesavre P; Noël LH
Nephrol Dial Transplant; 2005 Jul; 20(7):1392-9. PubMed ID: 15855209
[TBL] [Abstract][Full Text] [Related]
7. Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity.
Vizjak A; Rott T; Koselj-Kajtna M; Rozman B; Kaplan-Pavlovcic S; Ferluga D
Am J Kidney Dis; 2003 Mar; 41(3):539-49. PubMed ID: 12612976
[TBL] [Abstract][Full Text] [Related]
8. The clinical and pathological characteristics of Chinese patients with pauci-immune crescent glomerulonephritis.
Tang Z; Yao X; Hu W; Zeng C; Chen H; Liu Z; Li L
Chin Med J (Engl); 2001 Apr; 114(4):374-8. PubMed ID: 11780457
[TBL] [Abstract][Full Text] [Related]
9. Is presence of ANCA in crescentic IgA nephropathy a coincidence or novel clinical entity? A case series.
Bantis C; Stangou M; Schlaugat C; Alexopoulos E; Pantzaki A; Memmos D; Ivens K; Heering PJ
Am J Kidney Dis; 2010 Feb; 55(2):259-68. PubMed ID: 20042261
[TBL] [Abstract][Full Text] [Related]
10. Necrotizing crescentic glomerulonephritis without significant immune deposits: a clinical and serological study.
Bindi P; Mougenot B; Mentre F; Noel LH; Peraldi MN; Vanhille P; Lesavre P; Mignon F; Ronco PM
Q J Med; 1993 Jan; 86(1):55-68. PubMed ID: 8438051
[TBL] [Abstract][Full Text] [Related]
11. Antineutrophil cytoplasmic antibodies reacting with human neutrophil elastase as a diagnostic marker for cocaine-induced midline destructive lesions but not autoimmune vasculitis.
Wiesner O; Russell KA; Lee AS; Jenne DE; Trimarchi M; Gregorini G; Specks U
Arthritis Rheum; 2004 Sep; 50(9):2954-65. PubMed ID: 15457464
[TBL] [Abstract][Full Text] [Related]
12. The distribution and significance of renal infiltrating cells in patients with diffuse crescentic glomerulonephritis.
Tang Z; Wu Y; Hu W; Yao X; Zhou H; Chen H; Liu Z; Li L
Chin Med J (Engl); 2001 Dec; 114(12):1267-9. PubMed ID: 11793849
[TBL] [Abstract][Full Text] [Related]
13. [Rapid-detection GBM-ANCA ELISA. An emergency tool for the early diagnosis of type I and II rapidly progressive glomerulonephritis].
Arranz O; Ara J; Rodríguez R; Poveda R; Serra A; Solé-Amigó J; Fort J; Mirapeix E; Darnell A
Nefrologia; 2001; 21(4):349-54. PubMed ID: 11816510
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome.
Sinico RA; Di Toma L; Maggiore U; Bottero P; Radice A; Tosoni C; Grasselli C; Pavone L; Gregorini G; Monti S; Frassi M; Vecchio F; Corace C; Venegoni E; Buzio C
Arthritis Rheum; 2005 Sep; 52(9):2926-35. PubMed ID: 16142760
[TBL] [Abstract][Full Text] [Related]
15. Rare association of chronic lymphocytic leukemia/small lymphocytic lymphoma, ANCAs, and pauci-immune crescentic glomerulonephritis.
Henriksen KJ; Hong RB; Sobrero MI; Chang A
Am J Kidney Dis; 2011 Jan; 57(1):170-4. PubMed ID: 20974512
[TBL] [Abstract][Full Text] [Related]
16. Effects of methylprednisolone and cyclophosphamide pulse therapy on renal infiltrating cells in patients with crescentic glomerulonephritis.
Tang Z; Zhou H; Yao X; Hu W; Leishi L
Chin Med J (Engl); 1997 Mar; 110(3):206-9. PubMed ID: 9594342
[TBL] [Abstract][Full Text] [Related]
17. Pauci-immune crescentic glomerulonephritis.
Gupta RK
Indian J Pathol Microbiol; 2003 Jul; 46(3):357-66. PubMed ID: 15025274
[TBL] [Abstract][Full Text] [Related]
18. Role of antineutrophil cytoplasmic antibodies and glomerular basement membrane antibodies in the diagnosis and monitoring of systemic vasculitides.
Sinclair D; Stevens JM
Ann Clin Biochem; 2007 Sep; 44(Pt 5):432-42. PubMed ID: 17761028
[TBL] [Abstract][Full Text] [Related]
19. Dual anti-neutrophil cytoplasmic antibody-related pauci-immune crescentic glomerulonephritis in a patient with Sjögren's syndrome.
Lee IH; Kim SK; Kim MK
Rheumatol Int; 2016 Sep; 36(9):1327-34. PubMed ID: 27384449
[TBL] [Abstract][Full Text] [Related]
20. Differences between myeloperoxidase-specific and -nonspecific P-ANCA-associated renal disease.
Ohtani H; Wakui H; Komatsuda A; Chyzh KA; Hatakeyama T; Masai R; Okuyama S; Togashi M; Sawada K
Ren Fail; 2007; 29(2):183-7. PubMed ID: 17365934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
